Management of Chronic Septal Myocardial Infarction

Medical Management

• The European Society of Cardiology recommends ACE inhibitors for all patients post-MI in the absence of hypotension, hypovolemia, or renal failure 3, 4
• The American College of Cardiology recommends beta-blockers for secondary prevention and continued long-term 5
• The European Society of Cardiology recommends statins for lipid management 6
• The European Society of Cardiology recommends antiplatelet therapy (aspirin ± P2Y12 inhibitor based on revascularization status) 3

Heart Failure Management

• The European Society of Cardiology recommends diuretics (furosemide 20-40 mg IV/PO) for volume management if pulmonary congestion or volume overload exists 3, 4, 5
• The European Society of Cardiology recommends nitrates if no hypotension for symptom relief 3, 4
• The American College of Cardiology recommends titrating ACE inhibitors and beta-blockers to target doses as tolerated 5

Surveillance and Monitoring

• The European Society of Cardiology recommends baseline echocardiography to evaluate left ventricular systolic function and regional wall motion abnormalities 3
• The European Society of Cardiology recommends evaluating the presence of LV aneurysm or thrombus 3
• The American College of Cardiology recommends evaluating valvular function (particularly mitral regurgitation from papillary muscle dysfunction or LV remodeling) 1
• The American College of Cardiology recommends evaluating right ventricular function if inferior/posterior involvement 7

Clinical Follow-up

• The European Society of Cardiology recommends monitoring for development of heart failure symptoms 3
• The American College of Cardiology recommends assessing for arrhythmias (ventricular tachycardia risk with septal scar) 6
• The European Society of Cardiology recommends screening for ischemic symptoms suggesting incomplete revascularization 3

Revascularization

• The European Society of Cardiology recommends considering coronary angiography and revascularization if there is recurrent angina or evidence of ongoing ischemia in viable myocardium 3
• The European Society of Cardiology recommends considering coronary angiography and revascularization if there is heart failure with evidence of hibernating myocardium 3
• The American College of Cardiology recommends considering coronary angiography and revascularization if there are high-risk features on stress testing 2

Critical Pitfall: Late Mechanical Complications

• The American College of Cardiology recommends remaining vigilant for late ventricular septal rupture, which presents with new systolic murmur, acute heart failure, or cardiogenic shock 1, 2
• The American College of Cardiology recommends remaining vigilant for papillary muscle dysfunction, which causes progressive mitral regurgitation and heart failure 1
• The European Society of Cardiology recommends remaining vigilant for LV aneurysm formation, which risks thromboembolic events and ventricular arrhythmias 4

Special Consideration: If Mechanical Complication Develops Late

• The European Society of Cardiology recommends immediate stabilization with oxygen, inotropes, and IABP for hemodynamic support if VSR occurs 3, 4, 6
• The European Society of Cardiology recommends urgent surgical consultation for surgical repair, which remains the definitive treatment with 25-60% hospital mortality but 95% of survivors achieving NYHA class I-II 3, 6

Risk Factor Modification

• The European Society of Cardiology recommends smoking cessation 6
• The European Society of Cardiology recommends blood pressure control 3
• The American College of Cardiology recommends diabetes management 6
• The European Society of Cardiology recommends cardiac rehabilitation participation 3
• The American College of Cardiology recommends weight management and exercise as tolerated 6